Publication

Title: A genomics network established to respond rapidly to public health threats in South Africa
Authors: Msomi N, Mlisana K, Willianson C, Bhiman JN, Goedhals D, Engelbrecht S, Van Zyl G, Preiser W, Hardie D, Hsiao M, Mulder N, Martin D, Christoffels A, York D, Giandhari J, Wilkinson E, Pillay S, Tegally H, James SE, Kanzi A, Lessells RJ, de Oliveira T.
Journal: Lancet Microbe,https://doi.org/10.1016/S2666-5247(20)30116-6: (2020)

Abstract

In response to the COVID-19 pandemic, we created the Network for Genomic Surveillance in South Africa (NGS-SA) in May, 2020 with grants from the South African Medical Research Council and the South African Department of Science and Innovation. Our goal is to sequence the genome of at least 10?000 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to inform the public health response in South Africa. As of July 27, 2020, we have sequenced the genome of 500 isolates, which has provided insights into how and when it was introduced into the country, and information on its early spread through clusters of outbreaks in health-care facilities, workplaces, and other congregate settings.

To respond to the virus, we have taken advantage of the public health research communities that exist in South Africa, and have established a laboratory network that, similar to the COVID-19 Genomics UK Consortium1 launched in March, 2020, will be guided by the following six key principles: (1) sequencing close to sample collection; (2) being platform agnostic; (3) supporting locally relevant public health priorities, such as by controlling clusters of outbreaks; (4) ensuring rapid and responsible open data sharing; (5) creating a bioinformatics system to process and analyse data locally; and (6) producing timely reports to inform policy makers. In addition, we have embedded a training and capacity-building programme for local scientists and health-care workers.

Download: Full text paper

Citation: Msomi N, Mlisana K, Willianson C, Bhiman JN, Goedhals D, Engelbrecht S, Van Zyl G, Preiser W, Hardie D, Hsiao M, Mulder N, Martin D, Christoffels A, York D, Giandhari J, Wilkinson E, Pillay S, Tegally H, James SE, Kanzi A, Lessells RJ, de Oliveira T. A genomics network established to respond rapidly to public health threats in South Africa Lancet Microbe,https://doi.org/10.1016/S2666-5247(20)30116-6: (2020).

Media Coverage of this Publication:


Another coronavirus variant detected in SA, but no reason to panic - News24 - 2021-03-02

A new SARS-CoV-2 variant, which has dominated Covid-19 infections in Uganda and Rwanda, has been detected in South Africa. The announcement was made by Professor Tulio de Oliveira, director of the KRISP lab. However, de Oliveira told Health24 that is not a variant of concern, and that genome surveillance will monitor this and other variants


How a team of scientists worked tirelessly to help the COVID-19 response in Africa - KRISP News - 2020-08-25

Ahead of the emergence of the SARS-CoV -2 outbreak in South Africa KRISP started preparing for it. KRISP really rose to the occasion in the fight against COVID-19 pandemic in Africa. In the process, KRISP trained 1000s of health care workers, produced genomic protocols & capacitated dozens of laboratories in Africa to respond to the COVID-19 pandemic



KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).


Location: K-RITH Tower Building
Nelson R Mandela School of Medicine, UKZN
719 Umbilo Road, Durban, South Africa.
Director: Prof. Tulio de Oliveira